SEC 13F Intelligence

Foresite Capital Management Vi LLC / AKRO

Foresite Capital Management Vi LLC’s Akero Therapeutics Inc Com Position

Does Foresite Capital Management Vi LLC own Akero Therapeutics Inc Com (AKRO)? Not currently — the last reported position was 244.9K shares worth $12M in Q3 2025; the fund’s latest 13F (Q1 2026) no longer reports it.

Position Value
$12M
Q3 2025
Shares
244.9K
% of Portfolio
+4.49%
Quarters Held
4
position exited

Position History AKRO

Reported value by quarter
Q4 ’24: $10MQ4 ’24Q1 ’25: $15MQ1 ’25Q2 ’25: $13MQ2 ’25Q3 ’25: $12MQ3 ’25filingsflow.com
QuarterSharesValue% of Portfolio
Q3 2025244.9K$12M+4.49%
Q2 2025244.9K$13M+7.35%
Q1 2025365.0K$15M+8.09%
Q4 2024365.0K$10M+4.52%

Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Foresite Capital Management Vi LLC’s full portfolio or all institutional holders of AKRO.